Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis
Background. Hashimoto's thyroiditis (HT) and higher levels of thyroid‐stimulating hormone (TSH) have been proposed as risk factors for papillary thyroid cancer (PTC), but this issue is still being debated. The purpose of this study was whether HT was related to the risk of PTC over TSH. Methods...
Saved in:
Published in | Head & neck Vol. 33; no. 5; pp. 691 - 695 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.05.2011
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background.
Hashimoto's thyroiditis (HT) and higher levels of thyroid‐stimulating hormone (TSH) have been proposed as risk factors for papillary thyroid cancer (PTC), but this issue is still being debated. The purpose of this study was whether HT was related to the risk of PTC over TSH.
Methods.
We enrolled 1329 patients (1028 with PTC, 52 with follicular thyroid cancer, and 249 with benign disease) of 1490 patients who underwent thyroidectomy.
Results.
The TSH concentration was not different among patients with PTC or benign disease. Our study showed that men (odds ratio [OR] = 1.54; p = .049) and the presence of HT (OR = 2.96; p <.001) increased the risk of PTC. Moreover, HT was associated with multifocal cancer (p = .005) and smaller tumor size (p = .031), but it did not influence the extrathyroidal invasion or nodal metastasis.
Conclusion.
Clinicians who deal with thyroid nodules should pay particular attention to HT because it is a stronger predictor for PTC than other risk factors. © 2010 Wiley Periodicals, Inc. Head Neck, 2011 |
---|---|
Bibliography: | Korea Research Foundation - No. KRF-2004-041-E00152 istex:7359F4ED296F0B38422EAB054FBAB52431A1A676 ark:/67375/WNG-CTMD0NKV-M ArticleID:HED21518 This Abstract was presented at the 33rd Annual Meeting of the European Thyroid Association, Thessaloniki, Greece, September 20-24, 2008. This Abstract was presented at the 33rd Annual Meeting of the European Thyroid Association, Thessaloniki, Greece, September 20–24, 2008. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1043-3074 1097-0347 |
DOI: | 10.1002/hed.21518 |